A novel epithelial-mesenchymal transition-related gene signature for prognosis prediction in patients with lung adenocarcinoma.

Feng, Shengyu; Huang, Ce; Guo, Liuling; Wang, Hao; Liu, Hailiang

Feng, Shengyu; Huang, Ce; Guo, Liuling; Wang, Hao; Liu, Hailiang.

Afiliação

Feng S; Institute for Regenerative Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200123, China.
Huang C; Institute for Regenerative Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200123, China.
Guo L; Institute for Regenerative Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200123, China.
Wang H; Institute for Regenerative Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200123, China.
Liu H; Institute for Regenerative Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200123, China.

Heliyon ; 8(1): e08713, 2022 Jan.

Article em En | MEDLINE | ID: mdl-35036605

Palavras-chave

Epithelial-mesenchymal transition; Gene signature; Immunity; Lung adenocarcinoma; Risk model

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Heliyon Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google